ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Less Hazardous Cigarette Only Hope To Reduce Smoking Health Problems, Carter Advisor Says

November 25, 1977

Expanding Umbilical Cord Stem Cells Found Safe As Standard Transplant

December 26, 2008

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994

In The States: Illinois, Virginia approve Legislation Mandating Coverage of Care In Cancer Clinical Trials

June 4, 1999

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

HHS Inspector General: IRBs Vulnerable In Changing Research Environment-Report

July 10, 1998